Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barter

Showing results (201-210 of 390) with videos related to

Pageof 39
Sort By:
Atherosclerosis|June 16, 2015
To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysisBjörn W Karlson, Michael K Palmer, Stephen J Nicholls, et al.
European Journal of Preventive Cardiology|August 7, 2015
Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysisBjörn W Karlson, Michael K Palmer, Stephen J Nicholls, et al.
The Journal of Biological Chemistry|November 7, 1999
High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDLP Xia, M A Vadas, K A Rye, et al.
The Journal of Biological Chemistry|April 12, 2003
Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formationKerry-Anne Rye, Kevin Wee, Linda K Curtiss, et al.
Atherosclerosis|March 21, 2013
Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGERBjörn W Karlson, Stephen J Nicholls, Pia Lundman, et al.
European Journal of Preventive Cardiology|May 7, 2013
Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER databaseMike K Palmer, Stephen J Nicholls, Pia Lundman, et al.
Biochimica Et Biophysica Acta|May 11, 1984
Detection of lipid transfer protein activity in rabbit liver perfusateM Abbey, J K Savage, A M Mackinnon, et al.
Biochemistry|September 24, 2004
Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent mannerNeil J Hime, Kate J Drew, Chris Hahn, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 19, 2012
Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGERB W Karlson, P J Barter, M K Palmer, et al.
AIDS (London, England)|June 1, 1991
Pseudomonas septicaemia associated with HIVM R Nelson, D C Shanson, G J Barter, et al.
Pageof 39

Showing results (201-210 of 390) with videos related to

Sort By:
Pageof 39
Atherosclerosis|June 16, 2015
To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysisBjörn W Karlson, Michael K Palmer, Stephen J Nicholls, et al.
European Journal of Preventive Cardiology|August 7, 2015
Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysisBjörn W Karlson, Michael K Palmer, Stephen J Nicholls, et al.
The Journal of Biological Chemistry|November 7, 1999
High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDLP Xia, M A Vadas, K A Rye, et al.
The Journal of Biological Chemistry|April 12, 2003
Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formationKerry-Anne Rye, Kevin Wee, Linda K Curtiss, et al.
Atherosclerosis|March 21, 2013
Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGERBjörn W Karlson, Stephen J Nicholls, Pia Lundman, et al.
European Journal of Preventive Cardiology|May 7, 2013
Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER databaseMike K Palmer, Stephen J Nicholls, Pia Lundman, et al.
Biochimica Et Biophysica Acta|May 11, 1984
Detection of lipid transfer protein activity in rabbit liver perfusateM Abbey, J K Savage, A M Mackinnon, et al.
Biochemistry|September 24, 2004
Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent mannerNeil J Hime, Kate J Drew, Chris Hahn, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 19, 2012
Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGERB W Karlson, P J Barter, M K Palmer, et al.
AIDS (London, England)|June 1, 1991
Pseudomonas septicaemia associated with HIVM R Nelson, D C Shanson, G J Barter, et al.
Pageof 39